4//SEC Filing
Cobuzzi Robert Joseph Jr. 4
Accession 0001437749-22-018666
CIK 0001053691other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 5:52 PM ET
Size
9.1 KB
Accession
0001437749-22-018666
Insider Transaction Report
Form 4
Cobuzzi Robert Joseph Jr.
Chief Operating Officer
Transactions
- Disposition to Issuer
Common Stock
2022-08-01−121→ 1,204 total - Exercise/Conversion
Common Stock
2022-08-01+327→ 1,325 total - Exercise/Conversion
Restricted Stock Unit
2022-08-01−327→ 654 total→ Common Stock (327 underlying)
Footnotes (1)
- [F1]On August 1, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51. The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. All share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeother
Related Parties
1- filerCIK 0001799838
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 5:52 PM ET
- Size
- 9.1 KB